Clinical Trial Results:
A Randomized, Open-Label, Comparative, Multicenter Trial to Compare the Effects on Metabolic Parameters of Two NOMAC-E2 Batches (Pivotal Phase III and Commercial Batch) and a Monophasic COC Containing 150 μg LNG and 30 μg EE (Protocol No. P06447)
Summary
|
|
EudraCT number |
2009-017288-40 |
Trial protocol |
NL |
Global completion date |
03 Feb 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jun 2019
|
First version publication date |
08 Jun 2019
|
Other versions |
|
Summary report(s) |
Cancelled/ Withdrawn Memo |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.